Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
No results matched your search
DexCom Inc (DXCM)
Add to/Remove from a Portfolio
Add to Portfolio
397.78
+2.31
+0.58%
After Hours
393.05
-4.73
-1.19%
0:40:05 - Real-time Data
- Volume: 683,251
- Bid/Ask: 386.01 / 395.99
- Day's Range: 386.12 - 402.49
DexCom
397.78
+2.31
+0.58%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
- Overview
- Profile
- Historical Data
- Options
- Index Component
Prev. Close395.47
Day's Range386.12 - 402.49
Revenue1.93B
Open396.79
52 wk Range182.07 - 456.23
EPS4.99
Volume683,251
Market Cap38.26B
Dividend (Yield)N/A (N/A)
Average Volume (3m)950,751
P/E Ratio79.69
Beta0.78
1-Year Change41.32%
Shares Outstanding96,177,363
Next Earnings DateMay 04, 2021
What is your sentiment on DexCom?
Members' Sentiments:
or
Market is currently closed. Voting is open during market hours.
DexCom Inc News
DexCom EPS misses by $0.01, beats on revenue
By Seeking Alpha - Feb 11, 2021
DexCom (NASDAQ:DXCM): Q4 Non-GAAP EPS of $0.91 misses by $0.01; GAAP EPS of $3.48 beats by $2.69.Revenue of $568.9M (+22.9% Y/Y) beats by $13.44M.Press Release
DexCom Q4 2020 Earnings Preview
By Seeking Alpha - Feb 10, 2021
DexCom (NASDAQ:DXCM) is scheduled to announce Q4 earnings results on Thursday, February 11th, after market close.The consensus EPS Estimate is $0.92 (-20.0% Y/Y) and the...
Technical Summary
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Neutral | Buy |
| Technical Indicators | Strong Sell | Sell | BUY | Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Neutral | Neutral | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Emerging Patterns | |||||
| Abandoned Baby Bearish | 30 | Current | |||
| Engulfing Bearish | 30 | Current | |||
| Falling Three Methods | 30 | Current | |||
| Harami Bullish | 1D | Current | |||
| Harami Cross | 1D | Current | |||
| Completed Patterns | |||||
| Doji Star Bearish | 1W | 2 | Feb 07, 2021 | ||
| Dragonfly Bearish | 1W | 2 | Feb 07, 2021 | ||
| Abandoned Baby Bullish | 1D | 2 | Feb 24, 2021 | ||
Trending Stocks
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| Zenith Bank | 25.45 | 25.90 | 25.30 | -0.40 | -1.55% | 26.61M | 26/02 | ||
| Dangote Cement | 207.40 | 207.40 | 207.40 | -12.60 | -5.73% | 174.98K | 26/02 | ||
| Guaranty Trust Bank | 31.00 | 31.10 | 31.00 | -0.05 | -0.16% | 9.02M | 26/02 | ||
| UBA | 8.15 | 8.35 | 8.00 | -0.05 | -0.61% | 16.09M | 26/02 | ||
| Access Bank | 8.25 | 8.25 | 7.95 | +0.15 | +1.85% | 12.38M | 26/02 | ||
| Courteville | 0.21 | 0.21 | 0.20 | +0.01 | +5.00% | 1.37M | 26/02 | ||
| Sterling Bank | 1.700 | 1.710 | 1.710 | -0.020 | -1.16% | 1.29M | 26/02 | ||
| Lafarge Africa | 23.00 | 23.20 | 23.00 | -0.70 | -2.94% | 3.36M | 26/02 | ||
| Nestle Nigeria | 1,305.00 | 1,305.00 | 1,305.00 | -145.00 | -10.00% | 32.65K | 26/02 | ||
| Nigerian Breweries | 48.00 | 48.00 | 48.00 | -4.00 | -7.69% | 477.09K | 26/02 |
DexCom Inc Company Profile
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).
Read More
Write your thoughts about DexCom Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.